日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Codeveloping a Novel Intervention to Promote the Well-Being of Family Caregivers of Individuals With Spinal Cord Injury: Protocol for a Feasibility Randomized Control Trial

共同开发一种促进脊髓损伤患者家庭照护者福祉的新型干预措施:可行性随机对照试验方案

Mohammadi, Somayyeh; Erlander, Beth; Cathcart, Heather; Robillard, Julie M; Sauvageau, Sophia; Whitehurst, David G T; Pauly, Elena; Pagé, Brooke; Miller, William C

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Plk1 抑制剂和阿比特龙协同破坏有丝分裂并杀死不同来源的癌细胞,而不依赖于雄激素受体信号传导

Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, Maya Ridinger, Susan Dalrymple, Mannan Nouri, Fang Xie, Shohreh Varmeh, Oliver Jonas, Matthew A Whitman, Sen Chen, Saleh Rashed, Lovemore Makusha, Jun Luo, John T Isaacs, Mark G Erlander, David J Einstein, Steven P Balk, Michael B Yaffe

A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy

一种新型PLK1抑制剂onvansertib可有效增强MYC驱动的髓母细胞瘤对放射疗法的敏感性

Wang, Dong; Veo, Bethany; Pierce, Angela; Fosmire, Susan; Madhavan, Krishna; Balakrishnan, Ilango; Donson, Andrew; Alimova, Irina; Sullivan, Kelly D; Joshi, Molishree; Erlander, Mark; Ridinger, Maya; Foreman, Nicholas K; Venkataraman, Sujatha; Vibhakar, Rajeev

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas

Onvansertib 与紫杉醇联合治疗铂类耐药卵巢癌

Roberta Affatato, Michela Chiappa, Federica Guffanti, Francesca Ricci, Laura Formenti, Robert Fruscio, Marta Jaconi, Maya Ridinger, Mark Erlander, Giovanna Damia

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

新型口服 PLK1 抑制剂 Onvansertib 联合治疗复发或难治性急性髓系白血病患者的 Ib 期研究

Amer M Zeidan, Maya Ridinger, Tara L Lin, Pamela S Becker, Gary J Schiller, Prapti A Patel, Alexander I Spira, Michaela L Tsai, Errin Samuëlsz, Sandra L Silberman, Mark Erlander, Eunice S Wang

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

Polo 样激酶 1 (Plk1) 抑制剂与紫杉烷在三阴性乳腺癌中发挥协同作用

Antonio Giordano, Yueying Liu, Kent Armeson, Yeonhee Park, Maya Ridinger, Mark Erlander, James Reuben, Carolyn Britten, Christiana Kappler, Elizabeth Yeh, Stephen Ethier

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

通过检测尿液中循环肿瘤DNA监测早期肿瘤对靶向治疗的每日反应动态

Husain, Hatim; Melnikova, Vladislava O; Kosco, Karena; Woodward, Brian; More, Soham; Pingle, Sandeep C; Weihe, Elizabeth; Park, Ben Ho; Tewari, Muneesh; Erlander, Mark G; Cohen, Ezra; Lippman, Scott M; Kurzrock, Razelle

Urine test for EGFR analysis in patients with non-small cell lung cancer

非小细胞肺癌患者的尿液 EGFR 分析检测

Franovic, Aleksandra; Raymond, Victoria M; Erlander, Mark G; Reckamp, Karen L

BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

高级别结直肠神经内分泌肿瘤中的BRAFV600E突变可能预测对BRAF-MEK联合疗法的反应

Klempner, Samuel J; Gershenhorn, Bruce; Tran, Phu; Lee, Thomas K; Erlander, Mark G; Gowen, Kyle; Schrock, Alexa B; Morosini, Deborah; Ross, Jeffrey S; Miller, Vincent A; Stephens, Philip J; Ou, Sai-Hong Ignatius; Ali, Siraj M

Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders

一项前瞻性盲法研究,旨在检测系统性组织细胞增生症患者游离DNA中的BRAFV600E突变。

Hyman, David M; Diamond, Eli L; Vibat, Cecile Rose T; Hassaine, Latifa; Poole, Jason C; Patel, Minal; Holley, Veronica R; Cabrilo, Goran; Lu, Timothy T; Arcila, Maria E; Chung, Young Rock; Rampal, Raajit; Lacouture, Mario E; Rosen, Neal; Meric-Bernstam, Funda; Baselga, José; Kurzrock, Razelle; Erlander, Mark G; Janku, Filip; Abdel-Wahab, Omar